As of June 23, 2020
Dividends Policy
Considering the management performance and financial condition overall, Takara Bio recognizes a basic policy aimed for profit contribution, positioning the profit distribution to shareholders as an important issue for management as well as enhancing the internal reserves to strengthen the R&D activities of three business segments: Bioindustry, Gene Therapy, and AgriBio businesses.
Specifically, our policy calls for a target rate of around 20% of estimated profit calculated without considering extraordinary income or loss in the consolidated financial statements.
Dividend Trends
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 （Expected） |
||
|---|---|---|---|---|---|---|---|
| Dividend Per Share(yen) | 1Q | - | - | - | - | - | - |
| 2Q | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 3Q | - | - | - | - | - | - | |
| FY-End | 1.80 | 4.00 | 4.50 | 7.00 | 8.00 | 8.00 | |
| Total | 1.80 | 4.00 | 4.50 | 7.00 | 8.00 | 8.00 | |
| Amount of Dividends(million yen) | 216 | 481 | 541 | 842 | 963 | - | |
| Payout Ratio(%) | 16.2 | 35.6 | 23.2 | 23.0 | 25.2 | 37.1 | |
| Ratio of Total Amount of Dividends to Net Assets(%) | 0.4 | 0.8 | 0.9 | 1.3 | 1.5 | - | |
Share Buybacks
We have not bought back our shares as of today.
